When Chasing COVID-19 Market Opportunities, Watch For Regulatory Hurdles
Executive Summary
Companies offering OTC sample collection kits to help diagnose COVID-19 quickly fell under scrutiny in the US because the FDA hasn’t authorized any OTC tests.